Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01074489 · ClinicalTrials.gov registry record

Challenging the Gold Standard: Pilot Study Comparing Continuous Glucose Monitoring System (CGMS), Capillary Glucose Monitors and 3 Hour Glucose Tolerance Test (GTT) to Diagnose Gestational Diabetes Mellitus (GDM)

A clinical trial, sponsored by University of Cincinnati.

Completed
Registry status
7
Enrollment target

NCT01074489 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01074489 has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

The purpose of this research study is to compare 3 methods of measuring blood glucose (blood sugar) levels to see if the finger-stick method or the continuous glucose monitoring system is better than or as good as the 3 hour glucose tolerance test (GTT) for the diagnosis of gestational diabetes.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2010-02
Est. Completion 2014-12

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT01074489

The ClinicalTrials.gov registry entry for NCT01074489 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01074489 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01074489 about?

NCT01074489 is a clinical study titled "Challenging the Gold Standard: Pilot Study Comparing Continuous Glucose Monitoring System (CGMS), Capillary Glucose Monitors and 3 Hour Glucose Tolerance Test (GTT) to Diagnose Gestational Diabetes Mellitus (GDM)". The purpose of this research study is to compare 3 methods of measuring blood glucose (blood sugar) levels to see if the finger-stick method or the continuous glucose monitoring system is better than or as good as the 3 hour glucose tolerance test (GTT) for the diagnosis of gestational diabetes.

What is the current status of trial NCT01074489?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-02. Estimated completion is 2014-12.

Who is sponsoring clinical trial NCT01074489?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.